Remdesivir and Potential Interactions With Psychotropic Medications: A COVID-19 Perspective

Prim Care Companion CNS Disord. 2020 May 28;22(3):20com02664. doi: 10.4088/PCC.20com02664.

Authors

Zeeshan Mansuri¹, Bhumika Shah, Muhammad Khalid Zafar, Taranjeet Jolly^#, Shailesh Jain^#

Affiliation

¹ Texas Tech University Health Science Center at Odessa/Permian Basin, 2301 W Michigan Ave, Midland, Texas 79701. [email protected].

^# Contributed equally.

PMID: 32470232
DOI: 10.4088/PCC.20com02664

No abstract available

MeSH terms

Adenosine Monophosphate / adverse effects
Adenosine Monophosphate / analogs & derivatives*
Adenosine Monophosphate / pharmacokinetics
Adenosine Monophosphate / therapeutic use
Alanine / adverse effects
Alanine / analogs & derivatives*
Alanine / pharmacokinetics
Alanine / therapeutic use
Betacoronavirus / drug effects*
COVID-19
Coronavirus Infections / drug therapy*
Coronavirus Infections / virology*
Drug Interactions
Humans
Pandemics
Pneumonia, Viral / drug therapy*
Pneumonia, Viral / virology*
Psychotropic Drugs / pharmacokinetics*
Psychotropic Drugs / therapeutic use*
SARS-CoV-2

Substances

Psychotropic Drugs
remdesivir
Adenosine Monophosphate
Alanine